Patent ID: 9375396
Filing Date: 2016-06-28
CPC Classification: A61K,A61M,A61P

Claim Text:
1. An inhalation-type pharmaceutical composition for the treatment of heart disease, comprising a first gas and an atomized medicine, wherein the first gas comprises hydrogen and oxygen, the gas volume concentration of hydrogen in the inhalation-type pharmaceutical composition is between 2 to 96%, the atomized medicine is selected from a group comprising acetylsalicylic acid, clopidogrel, propranolol, atenolol, nadolol, carvedilol, nifedipine, diltiazem, verapamil, isosorbide dinitrate, nicorandil, nitroglycerin, and any combination thereof, wherein the first gas is a gas mixture of hydrogen and oxygen generated from electrolyzing water, and the volume ratio of hydrogen to oxygen is 2:1.